CA19-9 IRMA

DE50100


Immunoradiometric assay for the direct quantitative determination of the cancer associated antigen CA19-9 in human serum.

MethodIRMA
Tests100
Incubation Time / Conditions1 h, 1 h (RT/shaker) (optional only 2x30 min)
Standard Range15 - 240 U/ml
Sensitivity analytical0.3 U/ml
Final Sample Volume100 µl
Sample Typeserum
Sample Pretreatment -
Isotope / SubstrateI-125
kBq980.00
Internal Controls2
Max. Shelf Life (months)8 weeks
Regulatory StatusCE